These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 35679154)

  • 1. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.
    Buder K; Zirngibl M; Bapistella S; Meerpohl JJ; Strahm B; Bassler D; Weitz M
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009898. PubMed ID: 35679154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Schmidt M; Bassler D
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009898. PubMed ID: 26666581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Bassler D
    Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.
    Buder K; Zirngibl M; Bapistella S; Meerpohl JJ; Strahm B; Bassler D; Weitz M
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD009759. PubMed ID: 36166494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Schmidt M; Bassler D
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009759. PubMed ID: 26666580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Bassler D
    Cochrane Database Syst Rev; 2014 Feb; (2):CD009759. PubMed ID: 24569960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of extracorporeal photopheresis in pediatric patients with graft-versus-host disease after hematopoietic stem cell transplantation.
    Winther-Jørgensen S; Nygaard M; Heilmann C; Ifversen M; Sørensen K; Müller K; Masmas T
    Pediatr Transplant; 2019 Jun; 23(4):e13416. PubMed ID: 30973668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular manifestations of chronic graft-versus-host disease in patients treated with extracorporeal photochemotherapy.
    Motolese E; Rubegni P; Poggiali S; Motolese PA; Marotta G; Russo L; D'Ascenzo G; Carcagni MR; Fruschelli M; Motolese I; Fimiani M
    Eur J Ophthalmol; 2007; 17(6):961-9. PubMed ID: 18050124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
    Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
    Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study.
    Dal MS; Batgi H; Erkurt MA; Hindilerden IY; Kuku I; Kurtoglu E; Kaya E; Besisik SK; Berber I; Nalcaci M; Ulas T; Altuntas F
    Transfus Apher Sci; 2021 Oct; 60(5):103243. PubMed ID: 34420879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
    Alsuliman T; Magro L; Coiteux V; Gauthier J; Srour M; Lionet A; Beauvais D; Yakoub-Agha I
    Curr Res Transl Med; 2020 Apr; 68(2):71-76. PubMed ID: 31631014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
    Spałek A; Grygoruk-Wiśniowska I; Gruenpeter K; Panz-Klapuch M; Helbig G
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal photopheresis with TC-V in Japanese patients with steroid-resistant chronic graft-versus-host disease.
    Okamoto S; Teshima T; Kosugi-Kanaya M; Kahata K; Kawashima N; Kato J; Mori T; Ozawa Y; Miyamura K
    Int J Hematol; 2018 Sep; 108(3):298-305. PubMed ID: 29959747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease.
    Oarbeascoa G; Lozano ML; Guerra LM; Amunarriz C; Saavedra CA; Garcia-Gala JM; Viejo A; Revilla N; Acosta Fleitas C; Arroyo JL; Martinez Revuelta E; Galego A; Hernandez-Maraver D; Kwon M; Diez-Martin JL; Pascual C;
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):651-658. PubMed ID: 31917270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
    Richet C; Huynh A; Dimeglio C; Borel C; Lepage B; Boulinguez S; Marguery MC; Paul C; Bulai Livideanu C
    Dermatology; 2018; 234(1-2):23-30. PubMed ID: 29788024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
    Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
    J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.